Prescription drug monitoring program use and utility by Washington State pharmacists: A mixed-methods study. Pett, R. G., Mancl, L., Revere, D., & Stergachis, A. Journal of the American Pharmacists Association: JAPhA, 60(1):57–65, February, 2020.
doi  abstract   bibtex   
OBJECTIVES: To explore factors and situations that influence pharmacists to use the prescription drug monitoring program (PDMP) and to characterize actions taken by pharmacists after alarming scenarios from a PDMP query. DESIGN: Explanatory sequential 2-phase mixed-methods design: (1) cross-sectional Web-based survey of Washington State pharmacists followed by (2) interviews with purposefully selected respondents to explore statistically significant quantitative findings. SETTING AND PARTICIPANTS: The study was conducted in Washington State from September 2018 to February 2019. A total of 967 Washington State pharmacists from various practice settings, including inpatient and outpatient pharmacies, participated. Ten outpatient pharmacists were interviewed in the second phase. OUTCOME MEASURES: The pharmacists reported the frequency of PDMP use, opinion on the usefulness of PDMP, and action(s) taken after a concerning PDMP report. RESULTS: The usable response rate for pharmacists with a PDMP account was 17.6% (818/4659), and usable response rate for all pharmacists was 10.4% (967/9263). PDMP use varied by race, practice setting, and employer policy on PDMP use. Among the 818 PDMP users, 396 (48%) used the database at least once during a shift. Frequent PDMP users were more likely to recommend naloxone compared with less frequent users (adjusted odds ratio 1.70 [95% CI 1.09-2.65], P = 0.02). The following 3 interview themes were identified: time, company policy, and red flags. CONCLUSION: PDMP has value to pharmacists of all practice settings studied. Frequent PDMP use may facilitate more pharmacist interventions, such as a naloxone prescription.
@article{pett_prescription_2020,
	title = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists: {A} mixed-methods study},
	volume = {60},
	issn = {1544-3450},
	shorttitle = {Prescription drug monitoring program use and utility by {Washington} {State} pharmacists},
	doi = {10.1016/j.japh.2019.09.016},
	abstract = {OBJECTIVES: To explore factors and situations that influence pharmacists to use the prescription drug monitoring program (PDMP) and to characterize actions taken by pharmacists after alarming scenarios from a PDMP query.
DESIGN: Explanatory sequential 2-phase mixed-methods design: (1) cross-sectional Web-based survey of Washington State pharmacists followed by (2) interviews with purposefully selected respondents to explore statistically significant quantitative findings.
SETTING AND PARTICIPANTS: The study was conducted in Washington State from September 2018 to February 2019. A total of 967 Washington State pharmacists from various practice settings, including inpatient and outpatient pharmacies, participated. Ten outpatient pharmacists were interviewed in the second phase.
OUTCOME MEASURES: The pharmacists reported the frequency of PDMP use, opinion on the usefulness of PDMP, and action(s) taken after a concerning PDMP report.
RESULTS: The usable response rate for pharmacists with a PDMP account was 17.6\% (818/4659), and usable response rate for all pharmacists was 10.4\% (967/9263). PDMP use varied by race, practice setting, and employer policy on PDMP use. Among the 818 PDMP users, 396 (48\%) used the database at least once during a shift. Frequent PDMP users were more likely to recommend naloxone compared with less frequent users (adjusted odds ratio 1.70 [95\% CI 1.09-2.65], P = 0.02). The following 3 interview themes were identified: time, company policy, and red flags.
CONCLUSION: PDMP has value to pharmacists of all practice settings studied. Frequent PDMP use may facilitate more pharmacist interventions, such as a naloxone prescription.},
	language = {eng},
	number = {1},
	journal = {Journal of the American Pharmacists Association: JAPhA},
	author = {Pett, Ryan G. and Mancl, Lloyd and Revere, Debra and Stergachis, Andy},
	month = feb,
	year = {2020},
	pmid = {31753615},
	keywords = {Adult, Controlled Substances, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pharmacists, Prescription Drug Monitoring Programs, Washington, Young Adult},
	pages = {57--65},
}

Downloads: 0